ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy.

AIT is a proven therapeutic option for the treatment of allergic rhinitis, conjunctivitis, and/or asthma using sublingual (SLIT) or subcutaneous (SCIT) routes. Keywords: allergic rhinitis; asthma; immunotherapy; precision medicine EN allergic rhinitis asthma immunotherapy precision medicine 1 11 11 06/25/21 20210601 NES 210601 INTRODUCTION Allergen immunotherapy (AIT), the gradually increasing repeated administration of high doses of allergens to allergic patients, offers the potential for immune tolerance against reactions to the natural exposures to specific allergens. Allergic rhinitis, asthma, immunotherapy, precision medicine For patients with concomitant allergic rhinitis and sensitised to house dust mite - with persisting asthma symptoms despite low-moderate dose of inhaled corticosteroids - SLIT can be considered, provided FEV1 is >70% predicted. [Extracted from the article]